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CONTINUOUS THORACIC PARAVERTEBRAL NERVE BLOCKS IN 
PEDIATRIC PATIENTS 
SARA BITARAFAN 
ABSTRACT 
Studies that evaluate the use of ultrasound-guided continuous paravertebral nerve 
blocks in pediatric patients are scarce, although the use of peripheral nerve blocks has 
indeed increased in popularity in the adult demographic. The present study aims to 
describe the epidemiology, safety and efficacy of ultrasound-guided continuous thoracic 
paravertebral nerve blocks as an everyday practice on a large scale in pediatric patients at 
a busy, academic, tertiary-care hospital. In all patients studied, a linear ultrasound 
transducer was used via the transverse in-line technique for catheter placement. 
Transducer configuration (frequency of oscillation and probe length) was varied based on 
individual patient factors, such as age, weight and body mass index. A descriptive, 
retrospective chart review of all patients who received a continuous paravertebral nerve 
block within a two-year time frame, from 10/2012 to 10/2014, was conducted, resulting 
in a sample size of 238 paravertebral catheters placed in 214 patients.  
In regards to patient demographics, the median age was 2 years (IQR 0.8 years – 
12 years), with a range of 1 day to 18 years; and the average weight was 25.3 kg ± 23.6 
kg, with a range of 1.8 kg to 113.7 kg. The median catheter duration was 3 days (IQR 2 
days – 5 days), with 88.8% of catheters placed unilaterally, and 11.2% placed bilaterally. 
Median postoperative pain scores, intubation time, morphine equivalent consumption, 
and midazolam consumption were measured for all patients. The overall complication 
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rate was 16.8% (n = 36 patients) with a minor catheter complication rate of 16.4% (n = 
35). 6.1% (n = 13) of complications were due to catheter leakage, 4.7% (n = 10) due to 
catheter dislodgement, 2.8% (n = 6) due to skin irritation, 1.9% (n = 4) due to catheter 
occlusion and 0.9% (n = 2) due to minor bleeding at the site of catheter insertion. Only 
one patient experienced a major complication (0.5% of total patients), manifested as a 
self-resolving, 30-second seizure after a bolus administration of 2% chloroprocaine to 
manage postoperative pain. The patient was bag-mask ventilated for 60 seconds and the 
catheter was discontinued. No long-term sequelae were present in this case. Lastly, 
98.1% (n = 210) of patients experienced sufficient pain coverage, yielding a failed block 
rate of 1.9% (n = 4).   
These results demonstrate safety and efficacy of ultrasound-guided transverse in-
line continuous, thoracic paravertebral nerve block in pediatric patients, especially small 
infants and children. This technique provides an analgesic alternative to the thoracic 
epidural for postoperative pain treatment in pediatric patients.   
  
	  	   vi 
TABLE OF CONTENTS 
TITLE PAGE….………………………………………………………………………….. i 
COPYRIGHT PAGE.......................................................................................................... ii 
READER APPROVAL PAGE………………………………………………………….. iii 
ABSTRACT ....................................................................................................................... iv	  
TABLE OF CONTENTS ................................................................................................... vi	  
LIST OF TABLES ............................................................................................................ vii	  
LIST OF FIGURES ......................................................................................................... viii	  
LIST OF ABBREVIATIONS ............................................................................................ ix	  
INTRODUCTION .............................................................................................................. 1	  
METHODS ....................................................................................................................... 15	  
RESULTS ......................................................................................................................... 19	  
DISCUSSION ................................................................................................................... 25	  
LIST OF JOURNAL ABBREVIATIONS ....................................................................... 30	  
REFERENCES ................................................................................................................. 31	  
CURRICULUM VITAE ................................................................................................... 33	  
 
	  	   vii 
 
LIST OF TABLES 
Table Title Page 
1 Epidural block versus Continuous PVNB 6 
2 Postoperative Pain Scores 19 
3 Number and Percentage of Intubated Patients per 
Postoperative Day 
20 
4 Postoperative Opioid and Sedative Consumption 20 
5 Catheter Complication Rate  22 
6 Pain Coverage 23 
7 Pain Coverage Patient Demographics 24 
 
 
 
  
	  	   viii 
LIST OF FIGURES 
 
 
 
Figure Title Page 
1 Thoracic Ultrasound-Guided PVNB 4 
2 Median Pain Score 20 
3 Postoperative Opioid and Sedative Consumption  21 
4 Catheter Complication Rate 22 
5 Pain Coverage  23 
  
   
  
  
 
 
  
	  	   ix 
LIST OF ABBREVIATIONS 
 
ADARPEF  French-Language Society of Paediatric Anaesthesiologists 
AIMS   Anesthesia Information Management System 
BCH   Boston Children’s Hospital  
BCH-RAS  Boston Children’s Hospital Regional Anesthesia Service 
CSF   Cerebral spinal fluid 
DOS   Day of surgery 
FLACC  Face, Legs, Activity, Cry, Consolability  
GA   General anesthesia  
IICM   Internal intercostal membrane 
IQR   Interquartile Range 
LA   Local anesthesia 
NCA   Nurse-controlled intravenous analgesia  
NRS   Numeric Rating Score 
OR   Operating room 
PCA   Patient/parent-controlled intravenous analgesia  
POD   Postoperative day 
PRAN   Pediatric Regional Anesthesia Network  
PVNB   Paravertebral Nerve Block   
PVS   Paravertebral Space 
RA   Regional anesthesia  
SEP   Somatosensory Evoked Potential  
	  	   x 
VAS   Visual Analog Scale
	   1	  
INTRODUCTION 	  
Hugo Sellheim successfully performed the first paravertebral block on laparotomy 
patients in 1905, when he slowly injected procaine into what is now referred to as the 
paravertebral space.1 Regardless of the significant strides made in spinal anesthesia since, 
the paravertebral nerve block (PVNB) has only gained significant attention in the past 
couple of decades, owing to its recent surge of interest to Eason and Wyatt, who praised 
the efficacy and safety of the thoracic paravertebral block, especially in comparison to the 
more widely acclaimed epidural block, a commonly used type of central neuraxial block.2 
Though originally intended to decimate the adverse side affects associated with various 
central neuraxial blocks for special surgical procedures, the PVNB has recently been 
shown to provide adequate pain treatment with a low complication rate in adults during 
routine surgery and for post-operative pain control.  
 
BACKGROUND 
Of the several paravertebral nerve blocks, the lumbar and thoracic PVNB’s are 
the most widely used. As the name suggests, the lumbar plexus, or psoas compartment 
block, is used for lower limb pain management.3 Because a single nerve block may not be 
sufficient to cover a particular dermatome (a portion of skin supported by a single spinal 
root) due to the vast number of lower limb nerves, lumbar plexus blocks are frequently 
performed in concurrence with another nerve block.3  
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On the other hand, the thoracic PVNB is performed for breast, abdomen, chest 
and rib fracture surgery pain management, by injecting local anesthetic (LA) into the 
paravertebral space (PVS) in the dorsal region of the body. The PVS is a potential space, 
wedged in between the heads of the ribs, which lie superiorly and inferiorly. Medial to 
the PVS lie the vertebral body and intervertebral foramina, whereas the costotransverse 
ligament is located posteriorly, and the parietal pleura is located anterolaterally.2 
Injection of LA into this space causes specific dermatomes of the thoracic region to be 
either unilaterally or bilaterally blocked.4 A single shot of anesthetic can usually block 
two or three dermatomes at a time.1 Placement of a catheter during the time of service 
can help supply a continuous infusion of analgesia during post-operative treatment, 
thereby managing any resulting pain. Due to their lack of epineurium, the sympathetic 
nerves that fill the PVS can be easily accessed and affected by the injected local 
anesthetic.1 The resulting potent efficacy of local anesthetic in the paravertebral space 
can then reduce the amount of anesthetic, postoperative analgesia, and supplemental 
opioids used to achieve the same degree of pain management. By reducing the amount of 
analgesia administered, any resulting adverse events that could stem from opioid 
consumption can therefore be avoided. At Boston Children’s Hospital (BCH), the 
transverse in-line ultrasound-guided technique is used for local anesthetic administration 
and catheter placement.  
In order to visualize Tuohy needle advancement in the transverse, or axial, plane, 
the New York School of Regional Anesthesia (2013) suggests first placing a high 
frequency (10-12 MHz) transducer lateral to the transverse process, which is 
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characterized as a hyperechoic structure with an accompanying acoustic shadow below.4 
The transducer is then moved caudadly towards the PVS, a hypoechoic wedge-shaped 
space, defined posteriorly by the hyperechoic parietal pleura in the corresponding 
sonographic image, which is displaced downward upon injection of local anesthetic, 
indicating correct needle tip placement into the PVS.4 
Traditionally, the landmark technique has been employed, especially in pediatric 
patients, to administer local anesthetic into the PVS. This is done by simply identifying 
the transverse spinous process under direct vision with the patient either sitting upright or 
in the lateral decubitus position (lying on one side).2 The Tuohy needle is then moved 
laterally toward the desired PVS. When inserting the needle, a loss-of-resistance can 
sometimes be felt when the internal intercostal membrane is traversed, which signifies 
that the needles tip is within the PVS.4 However, the landmark approach has 
demonstrated a failure rate of >10% due to the inherent difficulty of needle placement, 
which is then associated with increased pain, pneumothorax and other more serious 
complications.5 With the aid of ultrasound-guidance, the rate of these adverse events has 
been decreased to nearly 1%, although a greater risk is still associated with bilateral 
PVNB’s.6 Thus, the benefit of having sonographic images that accurately display the 
depth of the PVS, and position of the needle in relation to the PVS and pleural cavity, 
proves its advantage over the landmark technique.  
Additional considerations include aspirating the catheter for blood and/or cerebral 
spinal fluid (CSF) prior to administration of anesthetic, as well as slow, meticulous, 
injection of anesthetic to reduce spread, especially into the epidural space.4 Lastly, 
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careful insertion and movement of the needle is necessary, even with ultrasound-
guidance, to avoid pneumothorax (lung collapse) or pleural puncture.  
 
Figure 1: Thoracic Ultrasound-Guided PVNB. A) Transducer positioning in relation to 
the Tuohy needle; B) corresponding sonographic image where TP = Transverse Process 
of the vertebral body and PV Space = Paravertebral Space; C) patient in oblique later 
position where the gray arrow indicates the left scapula, the white arrow indicates the 
paramedian line and the (>) markings represent the spinous processes; D) the needle path 
to the paravertebral space and the appropriate local anesthetic (LA) spread. Adapted from 
Vandepitte et al.4  
 
 
COMPARATIVE STUDIES 
Generally speaking, the available literature proves that the PVNB is safe and 
efficacious in adult patients. This has been evaluated by studying postoperative pain 
scores, opioid consumption, as well as the total duration of catheter placement and 
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hospital stay. Studies note that with PVNB use, the total opioid consumption can also be 
reduced, thereby reducing withdrawal symptoms, immunological disruptions, respiratory 
depression, discomfort, and pain. Although the epidural nerve block has been established 
as the “go-to” nerve block, recent studies demonstrate comparative analgesic effect 
between the continuous PVNB, epidural nerve blocks and general anesthesia.  
Having a continuous infusion of a local anesthetic, as opposed to a single shot 
local injection at the time of service, provides pain treatment during the post-operative 
period, as well as decreased adverse side effects related to anesthesia, such as improved 
respiration and oxygenation. According to Daly et al., “Thoracic surgery is associated 
with a 30% reduction in functional residual capacity and 50% reduction in vital capacity, 
for which uncontrolled postoperative pain is a major contributor.”7 With the addition of 
postoperative opioid pain relief, respiratory function is further impaired due to the 
inherently depressive nature of opioids. The improved respiratory function with 
continuous PVNB’s has been reflected in spirometry measurements, visual analog scale 
(VAS) pain scores at rest and during coughing, and blood oxygenation levels.8 By 
studying 15 patients with multiple fractured ribs, Karmakar et al. established that 
continuous PVNB of bupivacaine provides effective analgesia with fewer adverse 
respiratory and oxygenation side effects, and could therefore be a better alternative to the 
thoracic epidural.8 
Recent literature reviews report PVNB’s to have an estimated success rate of 
94%, which is significantly higher than the thoracic epidural.6 This success rate is 
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manifested in decreased postoperative pain, supplemental postoperative opioid 
administration, and in some cases, decreased hospital stay.9  
 
Table 1: Epidural block versus Continuous PVNB with regards to complications. SEP: 
somatosensory evoked potential. Adapted from Chelly, 2012.6 
 
 Epidural Continuous PVNB 
Laterality Bilateral As needed 
Hypotension Frequent Infrequent 
Postoperative Nausea and 
Vomiting 
Frequent No 
Urinary Retention Frequent No 
Pruritus Frequent No 
Risk of Spinal Cord Injury Low Extremely Low 
Risk of Respiratory Depression Yes No 
Preservation of Forced Vital 
Capacity After Thoracotomy 
55% of preoperative  75% of preoperative  
Degree of Neural Blockade Partial (SEPs maintained) Complete (SEPs ablated) 
Motor Blockade Outside 
Surgical Dermatomes 
Yes Minimal  
Severity of Bleeding 
Complications 
High Moderate 
Thromboprophylaxis Complicated Simple 
  
Furthermore, a review conducted by Daly et al. asserts that in addition to the fewer 
adverse side-effects, the PVNB’s simplicity and flexibility with regards to conduction 
conditions demonstrates its efficiency over the thoracic epidural.7 For example, to 
guarantee safety, thoracic epidural placement is commonly performed with the patient 
being minimally sedated before induction of anesthesia; however, a PVNB is commonly 
performed at any point before or after surgery and achieves the same level of safety.7 
Additionally, a PVNB, as opposed to a thoracic epidural, requires less convoluted and 
time-consuming routine supervision during the postoperative hospital stay, although 
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studies have not yet been able to firmly establish that the epidural will yield a longer 
hospital stay.7 Having safe and effective analgesia not only reduces morbidity and 
improves the recovery rate, but it also lowers overall hospital costs as a result. 
Additionally, flexibility in anesthetic administration and monitoring makes the PVNB a 
more desirable approach from a regional analgesia and an anesthesiologist standpoint.  
 A meta-analysis executed by Scarci et al. that studied the effectiveness of the 
PVNB across more than 184 articles concluded that the PVNB is at least as effective as 
the thoracic epidural in terms of analgesia, but with fewer resulting adverse side effects.10 
This was reflected in a reduced complication rate, lower Visual Analog Scale (VAS) pain 
scores both at rest and while coughing, better respiratory function, and lower plasma 
cortisol concentrations indicating less postoperative biological stress.10 Likewise, a 
similar meta-analysis also studied the effectiveness of the PVNB over the thoracic 
epidural in ten randomized trials.11 Paralleling the results uncovered by Scarci et al., this 
meta-analysis also demonstrated equal analgesic efficacy between thoracic epidurals and 
PVNB’s manifested in fewer postoperative side effects and a reduced failure and 
complication rate, but with no significant difference in postoperative pain scores or 
opioid consumption.11 As per usual, postoperative side effects in this case include nausea, 
vomiting, hypotension, and urinary retention. The reduced contraindications associated 
with the PVNB certainly question the thoracic epidural’s standing as an intraoperative 
anesthetic and postoperative analgesic gold standard. 
 In a prospective, randomized, double blind study that assessed the analgesic 
differences between thoracic epidurals, both with and without additional hydromorphone 
	   8	  
administration, and continuous PVNB, investigators utilized bupivacaine as their form of 
analgesia for patients undergoing thoracotomies to treat lung cancer.12 By assigning 
patients to three different groups (epidural with bupivacaine alone, epidural with 
bupivacaine and hydromorphone, and continuous PVNB with bupivacaine alone), Grider 
et al. were able to evaluate important differences in analgesia in concordance with the 
type of anesthetic and/or opioid. By comparison of VAS pain scores and incentive 
spirometer measurements, the group could determine that patients with the epidural 
infused with both bupivacaine and hydromorphone received better analgesia when 
compared to patients who received epidurals with bupivacaine alone and patients who 
received continuous PVNB’s with bupivacaine alone.12 The latter two groups received 
PCA hydromorphone postoperatively to treat pain, and there were no significant 
differences in the amount of PCA hydromorphone utilized between the two groups.12 
Nonetheless, the group suggested that a continuous PVNB of a local anesthetic does 
provide acceptable analgesia, paralleling the results of the two aforementioned meta-
analyses.12 Finally, this study highlights the potential importance of opioid infusion in 
addition to the anesthetic, as a way to lessen the rate of the basal infusion, and resulting 
postoperative treatment.  
 PVNB’s have also shown superior analgesic advantages when compared to 
general anesthesia (GA), or extradural infusions. One study demonstrated that out of 20 
patients undergoing thoracotomy surgery, only 13% of those who received a PVNB 
required postoperative pain treatment, whereas 50% of patients who received GA 
required postoperative pain treatment.13 In addition to this significant difference in pain 
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treatment, hospital stay and adverse side-effects associated with anesthesia were greatly 
reduced in the PVNB group, as opposed to the GA group.13 Similarly, a randomized, 
prospective study investigating 50 patients undergoing Inguinal Hernia repair surgery 
studied the difference in requisite pain treatment between patients receiving a PVNB and 
those receiving GA. Patients were randomly assigned to either of the two groups, and 
researchers found that those who received a PVNB enjoyed a shorter time-to-home 
readiness and discharge time, in addition to fewer adverse postoperative effects and better 
overall analgesia.14 Thus, similar to the thoracic epidural comparative studies, 
comparative studies that have assessed analgesic differences between PVNB’s and GA 
demonstrate significant advantages in favor of the PVNB.  
 
THE PEDIATRIC DEMOGRAPHIC 
 Although postoperative opioid administration has traditionally been the most 
common mode of analgesia in pediatric patients, regional anesthesia is frequently used as 
an adjunct analgesia. Continuous PVNB’s have recently shown promise in providing 
adequate postoperative pain treatment.15 In a prospective, non-comparative study, 
Karmakar et al. evaluated the safety and efficacy of continuous paravertebral infusions of 
bupivacaine to treat post-thoracotomy pain in 20 infants.15 Practitioners performed the 
nerve blocks under direct vision, and demonstrated safety without major comorbidities, 
such as pleural or vascular puncture.15 Furthermore, the data demonstrated an overall 
relatively low median pain score (0.52), with the rare high pain score (measured as a 
value greater than 3) being a direct result of catheter malfunction.15 The study concluded 
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that a continuous infusion of local anesthetic administered through catheters placed under 
direct vision, without ultrasound guidance, is a safe and effective mode to treat 
postoperative pain, even in small neonates, with a more favorable side effect profile and 
reduced complication and failure rate, especially when compared to other regional 
anesthesia (RA) procedures.15 Although these pediatric patients had a low complication 
and side effect rate, it’s important to note that the majority of failed blocks were 
attributed to catheter malfunction. This highlights the need for a more advanced 
methodology for catheter production, placement, and postoperative monitoring.   
In order to evaluate the safety and efficacy of RA in pediatric patients, in 1996 the 
French-Language Society of Paediatric Anaesthesiologists (ADARPEF) conducted a one-
year prospective study using data pooled from multiple institutions.16 Ultimately, 
researchers found an increased safety rate with peripheral nerve blocks, compared to 
central nerve blocks, and have since urged anesthesiologists to utilize peripheral nerve 
block techniques with pediatric patients as much as possible.16 Twelve years later, the 
ADARPEF published a follow-up study to analyze the morbidity and epidemiology of 
RA in pediatric patients, compared to GA. Again, the ADARPEF pooled data from 
multiple institutions in a one-year prospective study, looking at a total of 47 hospitals 
located globally.16 Both studies were conducted without the use of ultrasound guidance. 
Patients were separated into three groups: GA, GA in concordance with RA, and RA only 
(34% of which were central nerve blocks, including caudal, and 66% of which were 
peripheral nerve block, with a 9% catheter placement rate across both groups).16 Though 
the overall complication rate between catheter and non-catheter groups was insignificant, 
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the complication rate for central neuraxial blocks was seven times higher than the 
peripheral nerve block complication rate, especially for the youngest patient groups, 
following in suite of the ADARPEF’s original 1996 study that demonstrated a greater 
safety and efficacy with the peripheral nerve block.16 Furthermore, the ADARPEF’s 
follow-up study effectively demonstrated a reduced complication rate with RA when 
compared to GA, and suggested that practitioners should continue to opt for peripheral 
nerve block, such as the PVNB, whenever appropriate.  
 Following the ADARPEF’s second study, Polaner et al. sought to accomplish a 
similar observational, multi-institutional, prospective study to evaluate the safety and 
efficacy of RA for pediatric patients, utilizing a more rigorous auditing system so as to 
yield more accurate and precise data.17 Pooling data from across various U.S. hospitals 
into a central database, the Pediatric Regional Anesthesia Network (PRAN), researchers 
were able to record the type of anesthesia and the technique utilizing, as well as any 
corresponding complications across a total of 14,917 nerve blocks performed on 13,725 
pediatric patients.17 With a greater focus on comparing and contrasting continuous 
(catheter) nerve blocks with single-shot nerve blocks, in addition to an acknowledgement 
of ultrasound guidance, the PRAN data were able to shed light on more up-to-date 
considerations with regard to common analgesic practices, and therefore a broader goal 
of large-scale quality improvement. Most relevant to the discussion was the finding that 
43% of recorded complications were a direct result of the catheter, most common being 
postoperative malfunctions (i.e. kinked or dislodged), with 9% of complications 
corresponded to a completely failed nerve block.17 As a result, researchers assert the high 
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priority need for better catheter placement methods so as to reduce this relatively high 
complication rate.17 Paralleling the ADARPEF study, investigators noted an increase in 
peripheral nerve blocks in pediatrics, attributing the increase to the increased utilization 
of ultrasound guidance.17 Most importantly, the PRAN study reaffirmed that RA is a safe 
mode of anesthesia and analgesia in pediatric patients due to the its relatively low 
complication rate.17  
 Indeed, the use of ultrasound guidance, which in and of itself is attributed to 
increased safety and efficacy of block placement, has corresponded to a dramatic shift 
from central neuraxial blocks to peripheral nerve blocks as a commonplace procedure in 
pediatric anesthesia. On the onset of continuous PVNB popularity, the nerve block was 
traditionally used for special case procedures. For example, to evaluate the efficacy of the 
bilateral thoracic PVNB under ultrasound guidance, 30 Nuss procedure pediatric patients 
were enrolled in a prospective, comparative, observer-blind study at the West China 
Hospital of Sichuan University.18 By measuring postoperative complication rates, pain 
scores (via the Face, Legs, Activity, Cry, Consolability (FLACC) scale for patients under 
7 years of age and VAS for patients over 7 years of age), total opioid consumption, and 
attempts at the PCA pump, the group was able to compare the efficacy and safety of 
continuous infusions of bilateral thoracic PVNB’s performed under ultrasound guidance 
with a control group that was only given postoperative opioids for pain management.18 
The need for this study stemmed from the negative side effect profile associated with 
postoperative systemic opioid administration, which includes, respiratory depression, 
nausea, vomiting, oxygen desaturation, and negative behavioral changes.18 Postoperative 
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negative behavioral changes, a direct result of unmanaged pain, is specifically prevalent 
in the pediatric demographic, observed to last up to several months after surgery, and 
include increased anxiety, bedwetting, nightmares, and eating disorders.18 Ultimately, Qi 
et al. determined that continuous, thoracic, bilateral PVNB’s are indeed more effective at 
managing postoperative pain than intravenous opioid administration, noting the decreased 
pain scores, complication rate and negative behavioral changes in the experimental 
group.18 Furthermore, researchers suggested that ultrasound guidance may be a prominent 
contributor to the growing success of PVNB placement, and resulting safety and efficacy 
of its analgesic properties.18 Nonetheless, a larger study is necessary to reaffirm this 
notion.  
 One of the more recent studies to describe the continuous PVNB catheter placed 
under ultrasound guidance evaluated 22 pediatric patients retrospectively, from 6 months 
and 6 kg to 17 years and 135 kg.19 Boretsky et al. found that ultrasound guided PVNB 
catheter placement via an in-line technique yielded low FLACC and Numeric Rating 
Score (NRS) pain scores four days postop, reduced postoperative opioid consumption 
two days postop, and no recorded complications.19 These results affirm the safety and 
efficacy of thoracic PVNB catheter placement under ultrasound guidance in infants and 
children. Lastly, this study employs the same PVNB catheter placement methodology and 
research methodology as the currently described study.  
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OBJECTIVES 
 
Though the literature concerning large sample evaluations of regional anesthesia 
use in pediatric patients is comprehensive, the evidence concerning the efficacy and 
safety of ultrasound guided PVNB for thoraco-abdominal surgery is scarce, with limited 
data from studies with small sample sizes. Because the development of new technologies 
and high frequency ultrasound guidance has shown promise in the scant number of 
studies available, data from larger-scale studies is warranted.  
Therefore, the principal purpose of this study is to describe the use and 
epidemiology of ultrasound guided, continuous paravertebral nerve blocks at the Boston 
Children’s Hospital – a busy, academic, pediatric, tertiary-care institution – via 
descriptive, retrospective chart review. The goal is to demonstrate safety and efficacy of 
the paravertebral nerve block by assessing postoperative pain scores, total supplemental 
opioid consumption, and documentation of any procedural complications. 
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METHODS 	  
All pediatric patients (≤18 years of age) who underwent a paravertebral nerve 
block placement at Boston Children’s Hospital from October 2012 to October 2014 were 
included in the study, yielding a sample size of 238 paravertebral catheters placed in 214 
pediatric patients within a two-year time span. For all cases evaluated, a linear transducer 
was used with variability in frequency in oscillation and length based on patient age, 
weight and body mass index (BMI).  	  	  
CATHETER INSERTION METHODOLOGY 
 
 
 Patients receiving a unilateral PVNB were positioned laterally, so that the 
operative side was facing up, while patients receiving a bilateral PVNB were positioned 
full prone, with the face down. Bilateral PVNB patients could have also been positioned 
laterally initially, with the shoulders arched, making a 45-degree angle with the operation 
bed, exposing both sides of the patient’s back. After having the relevant thoracic level 
marked via the landmark technique, the patient was then prepped and draped in 
preparation for the needle insertion. As previously stated, ultrasound probe configuration 
was determined based on individual age, weight and BMI patient characteristics. This 
study followed an identical methodology for probe configuration as Boretsky et al.’s 
study: 
“For patients <5 years or under 18 kg, a 2.5-cm linear transducer oscillating at 6-13 MHz was 
used (SonoSite L25x; Bothell, WA, USA). For patients over 5 years of age and with a BMI <30, 
a 5-cm linear probe oscillating at 6-15 MHz was used (SonoSite HFL50x). For the patients with a 
BMI >30, a 3.8-cm linear probe oscillating at 5-10 MHz was used (SonoSite L38xi). The 
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ultrasound was sheathed in a sterile fashion and placed in a transverse orientation over the 
midline of the back at the designated dermatome level… Probe length was chosen to allow flat 
contact with the surface of the patient’s back and to ensure adequate depth to visualize the pleura 
while optimizing clarity of structures. On patients with high BMI a lower frequency probe was 
needed because of the increased depth from the skin to paravertebral space. In some of the obese 
patients, the IICM could not be visualized and the needle was advanced until it was just above the 
pleura. ”19 
 
 Once the transverse spinal process was identified and a 5 or 10cm, 18 gauge 
Tuohy needle that was advancing medially, breached the internal intercostal membrane 
(IICM), a few milliliters (mL) of saline were injected into the potential wedge-shaped 
space between the parietal pleura and transverse process’ acoustic shadow, which would 
identify correct needle placement in the PVS. Saline was used in an attempt to minimize 
the systemic concentration of local anesthetic in patients. Negative aspiration for blood 
and/or CSF was then conducted, and 0.5 ml/kg of 0.5% ropivacaine was injected on each 
side, if appropriate, totaling up to a maximum 15 mL of local anesthetic per block. Next, 
a single-orifice catheter (B. Braun Medical Inc., Bethlehem, PA, USA) was advanced 2-3 
cm past the needle tip.19 Correct catheter placement was confirmed by additional normal 
saline injection, viewed as a displacement of the pleura on the corresponding sonographic 
image. This process was then repeated on the other side if the patient was receiving a 
bilateral nerve block, and catheters were finally held and protected with clear adhesive.  
 The Regional Anesthesia Team introduced infusions of LA either in the operating 
room (OR) or the PACU, using a total of 0.5 mg/kg/hr 0.2% ropivacaine, with a 
maximum dose of 12mL/hr per block, for patients weighing greater than 50 kg.19 For 
patients weighing less than 50 kg, either 0.1% or 0.2% ropivacaine was used, achieving 
the same total dose of 0.5 mg/kg/hr.19 If a patient received a bilateral thoracic PVNB, the 
	   17	  
total anesthetic dose was divided equally between the two catheters. During the 
postoperative hospital stay, the Pediatric Acute Pain Treatment Service would exam 
patients twice per day, and adjusted pain treatment if necessary. The Perioperative Pain 
Team made note of all post-operative data in Notegen, a password-protected IT-
supported software, including all adverse events, clinical effectiveness measures, side 
effects, and all noteworthy incidents. 
 
 
DATA COLLECTION METHODOLOGY 
 
 
During the six-month data collection period, the BCH Regional Anesthesia 
Service (BCH-RAS) data were collected from individual electronic medical records, with 
a primary focus on extracting data from SurgiNet, which includes automated electronic 
medical record documentation, and Notegen, which includes data recorded 
postoperatively by the Pediatric Acute Pain Treatment Service. Using patient medical 
record numbers, AIMS and Notegen were used to extract data regarding the patient age, 
weight, type of PVNB used (either unilateral or bilateral), date of service, duration of 
catheter insertion, VAS, NRS and FLACC pain scores, total intubation time, total post-
operative opioid consumption and any significant post-operative incidents and/or 
complications. The appropriate data were collected up to five days after the date of 
operation and service, and were recorded in a password-protected Excel spreadsheet with 
anonymous patient identifiers. Though the NRS and FLACC scales are VAS scales, the 
FLACC pain scale was used for children 7 years or younger, while the NRS pain scale 
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was used for children older than 7 years of age. Opioid consumption data was converted 
to median morphine equivalents consumed per day prior to analysis. Furthermore, due to 
the particular nature of the patient demographic, the data were not normally distributed, 
and as such, are depicted, for the most part, as median values and interquartile ranges. 	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RESULTS 	  
 Of the 238 continuous paravertebral nerve blocks that were placed in 214 patients 
to manage pain for various thoraco-abdominal surgeries, 88.8% were bilateral and 11.2% 
were unilateral. Patients ranged from 1-day-old to 18 years of age, with a median of 2 
years (IQR 0.8 years – 12 years) and an average age of 6.1 years ± 6.4 years. Patients also 
ranged from 1.8kg to 113.7 kg, with an average weight of 25.3 kg ± 23.6 kg, and a 
median weight of 13.2 kg (IQR 7.6 kg – 41 kg). Finally the median duration of catheter 
insertion was 3 days (IQR 2 days – 5 days).  Tables 2 – 7 show additional study results.   
 
 
Table 2: Postoperative Pain Scores. POD = Postoperative Day  
 
 
VAS/NRS/FLACC 
Pain Score 
 
POD 1 
 
POD 2 
 
POD 3 
 
POD 4 
 
POD 5 
 
Median  
 
2 
 
1.9 
 
1.5 
 
1 
 
1 
 
Interquartile Range 
 
0.4 – 3.1  
 
0.5 – 3.4 
 
0.2 – 2.8 
 
0 – 2.3 
 
0 – 2.3 
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Figure 2: Median pain score over five postoperative days 
 
Table 3: Number and Percentage of Intubated Patients per Postoperative Day  
 
The average intubated time was 3.5 days ± 8.3 days, with a median of 0 days 
(IQR 0 – 4 days), and a range of 0 days to 75 days.  
 
Table 4: Postoperative Opioid and Sedative Consumption 
Opioid 
(mg/kg/day) 
DOS POD 1 POD 2 POD 3 POD 4 POD 5 
Morphine 
Equivalent 
Median 
 
0.16 
 
0.2 
 
0.05 
 
0 
 
0 
 
0 
Morphine       
0 
2 
4 
6 
8 
10 
12 
POD 1 POD 2 POD 3 POD 4 POD 5 
Pa
in
 S
co
re
 
 POD 1 POD 2 POD 3 POD 4 POD 5 
 
Number of 
Patients 
 
74 
 
65 
 
62 
 
57 
 
51 
 
Percentage of 
Total Patients 
 
34.6% 
 
30.4% 
 
29.0% 
 
26.6% 
 
23.8% 
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Equivalent 
IQR 
0.05 – 1.45 0.05 – 2.04 0 – 1.73 0 – 1.63 0 – 1.56 0 – 0.68 
Midazolam 
Median 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
Midazolam 
IQR 
 
0 – 1.2 
 
0 – 1.5 
 
0 – 0.15 
 
0 – 0.05 
 
0 – 0.03 
 
0 
 
 
 
Figure 3: Postoperative Opioid and Sedative Consumption. Eq. = Equivalent. The red 
box shows the morphine equivalent 50th percentile with error bars ranging from the 
lower 25th percentile, or first interquartile, to the 75th percentile, or third interquartile. 
Thus, the interquartile range is graphically represented for both morphine equivalent 
values and midazolam values in mg/kg/day. The orange error bars represent the 75th 
percentile of midazolam per postoperative day. Because the median and first IQR are 
both zero, only the 3rd IQR, or 75th percentile, could be graphed.   
 
The total range of morphine equivalent consumption was 0 mg/kg/day to 133.4 
mg/kg/day, and the total range of midazolam consumption was 0 mg/kg/day to 47.04 
mg/kg/day.  
0 
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Table 5: Catheter Complication Rate 
 Catheter 
Dislodgement 
Catheter 
Occlusion 
Catheter 
Leakage 
Skin 
Irritation 
Minor 
Bleeding 
Total 
Complications 
Number of 
Patients 
 
10 
 
4 
 
13 
 
6 
 
2 
 
35 
Percentage 
of Total 
Patients 
 
4.7 
 
1.9 
 
6.1 
 
2.8 
 
0.9 
 
16.4 
 
 
 
 
Figure 4: Catheter Complication Rate  
 
 
Catheter complications were measured against the total number of patients who 
received a continuous PVNB, as opposed to the total number of catheters placed. The 
only major complication (0.5% of total patients) that occurred involved a 1ml/kg bolus 
Dislodgment 
4.7% 
Occlusion 
1.9% Leakage 
6.1% 
Skin Irritation 
2.8% 
Minor 
Bleeding 
0.9% 
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injection of 2% chloroprocaine via catheter in a 9.4 kg, 1-year-old patient in order to 
manage pain on postoperative (POD) 1. The analgesic infusion resulted in a 30-second 
seizure, while the patient was bag-mask ventilated for 60 seconds. The catheter was 
promptly discontinued, and the patient recovered after 5 minutes. No long-term sequelae 
ensued. Thus, the total complication rate, both major and minor, is 16.8%. 
 
Table 6: Pain Coverage 
Pain Control Sufficient Insufficient 
 
Number of Patients 
 
210 
 
4 
 
Percentage of Total Patients 
 
98.1 
 
1.9 
 
 
 
Figure 5: Pain Coverage 
 
Sufficient 
98% 
 
Insufficient 
2% 
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Table 7: Pain Coverage Patient Demographics 
 Age  
(years) 
Weight  
(kg) 
Type of 
Catheter 
Duration of 
Catheter 
Insertion 
(days) 
Coverage 
Patient 1 0.92 7.7 Unilateral 11 Incomplete 
Patient 2 1 9.4 Unilateral 1 None 
Patient 3 15 67.1 Bilateral 3 None 
Patient 4 16 44.15 Unilateral 2 Incomplete 
 
No instances of insufficient pain coverage were due to catheter malfunctions.  
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DISCUSSION 
 
So far, there have been limited data describing the use of the continuous PVNB in 
the pediatric population. The underlying study is the largest scale data collection 
evaluating the safety and efficacy of continuous PVNB’s in pediatric patients, especially 
neonates and small children. This study demonstrates that the continuous, thoracic PVNB 
is a valid analgesic alternative to the thoracic epidural, with few associated adverse side 
effects and complications.  
Looking at the patient demographics, it’s clear that the majority of patients 
studied were very young. The median age of 2 years (IQR 0.8 years – 12 years), in 
addition to a median weight of 13.2 kg (IQR 7.6 kg – 41 kg), naturally focuses the study 
on infants and small children. Furthermore, the duration of catheter insertion was 3 days 
(IQR 2 days – 5 days), focusing the time frame of the study to five days after the date of 
service.  
 
PAIN SCORES 
 
 
Due to the study’s focus on infants and small children, it should be no surprise 
that a good number of patients were therefore intubated for a substantial amount of time 
postoperatively, which is reflected in the average intubation time of 3.5 days ± 8.3 days.   
This partially explains the low median pain scores throughout the five postoperative days 
evaluated, since many patients were intubated and paralyzed. Sedated and intubated 
infants were evaluated for pain mainly by heart rate, blood pressure and respiratory rate, 
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all of which would increase if the patient experienced any pain. Additionally, opioids 
were titrated to patient comfort, if necessary. If any discomfort were to be presented, the 
patient would immediately receive a supplemental infusion of narcotics and sedatives to 
manage pain, further explaining the low median pain scores.  The IQR’s increased around 
POD 2, which suggest that a greater number of patients experienced an increase in pain. 
This could be due to catheter malfunction or reduced efficacy of the analgesia. Usually if 
the catheter proved ineffective, blocked, kinked, or dislodged, it was simply removed, 
and postoperative pain was then treated with opioids. Often, the plan for many patients 
would be to discontinue the catheter after three days or less, which explains the median 
catheter duration of 3. Any subsequent pain would also be managed by opioids and 
sedatives until the patient felt comfortable.   
 
OPIOID CONSUMPTION 
 
 
All analgesic drugs were converted to morphine equivalents to evaluate total 
analgesia administration. Midazolam, a benzodiazepine and sedative, was also 
administered to alleviate pain and discomfort. Thus, total midazolam consumption was 
also calculated. Following the same trend as the median postoperative pain scores, the 
range of opioid consumption increased between postoperative days one and two. This 
increase could be due to the discontinuation of analgesic infusion and subsequent catheter 
removal. Regardless, narcotics were titrated to comfort for all patients upon observance 
of pain, resulting in the low median analgesia and sedative consumption per day.   
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Representing the amount of analgesia in mg/kg per postoperative day, the median 
morphine equivalent consumption, though initially low, continued to drop to zero by the 
third postoperative day (see Figure 3). The top end of the 50th percentile (red box) 
represents the median morphine equivalent consumption. Similarly, representing the 
amount of sedative consumption in mg/kg per postoperative day, the median midazolam 
amount was zero for every postoperative day, including the date of surgery (DOS). 
Because of the low medians, only the IQR could be graphically represented. However, 
large ranges of opioid administration were recorded for both sets of opioids. This is due 
to the inherent nature of the studied demographic – while neonates required very little 
opioids for pain management, older children generally required much more, a result of 
both size and individual patient factors. Nonetheless, both analgesia and sedative 
consumption were low for each postoperative day, as reflected in the respective medians 
per postoperative day. These data demonstrate the efficacy of the continuous PVNB for 
the management of postoperative pain.  
 
CATHETER COMPLICATION RATE 
 
 
We were able to demonstrate safety with the continuous PVNB due to a 
complication rate of 16.8%. Catheter malfunctions were the primary cause of minor 
complications, and the only major complication resulted from a 2% chloroprocaine 
administration, which could arguably be independent of the continuous PVNB, and 
rather, dependent on individual patient factors. Among the minor catheter complications, 
the primary catheter malfunction was catheter leakage, followed by catheter 
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dislodgement and skin irritation. Again, a usual reaction to catheter malfunction was 
discontinuation of the catheter, and administration of opioids to manage pain. 
Nonetheless, the rate of minor complications is relatively low, proving the continuous, 
thoracic PVNB to be a safe anesthetic and analgesic technique. Furthermore, the pain 
coverage data also affirms that the majority of patients (98.1%) in the sample received 
sufficient postoperative analgesia.  
 
SUMMARY 
 
 
 Due to the low pain scores, low supplemental opioid consumption, relatively low 
complication and failure rate, this study demonstrates safety with and efficacy of the 
transverse in-line ultrasound-guided continuous thoracic paravertebral nerve block in 
pediatric patients, especially infants and small children. Furthermore, the continuous, 
thoracic paravertebral nerve block has demonstrated comparative analgesia to the 
thoracic epidural, but with a more favorable side effect profile.  
 Limitations to this study most notably include inconsistent medical record 
documentation within individual patient records and across patient records. This 
inconsistent documentation calls for a high priority need to develop a standard 
documentation practice, and a more vigilant attention to meticulous documentation, so as 
to avoid inexact retrospective data collection, and in attempt to work towards the greater 
goal of quality improvement. Additionally, the retrospective and non-comparative nature 
of the study is also a limitation.   
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 Other steps that can be taken towards quality improvement include a study 
assessing the pharmacokinetics of local anesthetic. As of now, the optimal dosing 
regimen and toxicity levels for pediatric patients have not been established. Furthermore, 
a study comparing the pharmacokinetics of different local anesthetics could also prove 
beneficial. Additionally, the prominent contribution of catheter malfunctions to the rate 
of minor complications in this study, calls for a re-evaluation of catheter placement 
technique. An advanced methodology in this field could greatly improve the quality of 
pain treatment. Lastly, a large, randomized, prospective, double-blinded, comparative 
study should be conducted to evaluate the safety and efficacy of ultrasound-guided, 
continuous, thoracic PVNB’s compared to other regional anesthesia techniques, to 
determine more established alternatives to traditional modes of anesthesia and 
postoperative pain treatment.  
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